FUDiabetes

TOL-3021 Starts A Phase-II Clinical Trial

joshualevy October 19, 2019, 8:24pm #1

I just wrote a new blog, which you can read here:

cureresearch4type1diabetes.blogspot.com

TOL-3021 Starts A Phase-II Clinical Trial

TOL-3021 causes the body to generate proinsulin so that over time the immune system will get used to (or tolerate) it. Proinsulin and insul...

This is the second human trial for TOL-3021.

2 Likes

Home
Categories
FAQ/Guidelines
Terms of Service
Privacy Policy

Powered by Discourse, best viewed with JavaScript enabled